ES2062012T3 - Compuestos de benzodiazepina y su uso como productos farmaceuticos. - Google Patents

Compuestos de benzodiazepina y su uso como productos farmaceuticos.

Info

Publication number
ES2062012T3
ES2062012T3 ES89308099T ES89308099T ES2062012T3 ES 2062012 T3 ES2062012 T3 ES 2062012T3 ES 89308099 T ES89308099 T ES 89308099T ES 89308099 T ES89308099 T ES 89308099T ES 2062012 T3 ES2062012 T3 ES 2062012T3
Authority
ES
Spain
Prior art keywords
alkyl
formula
group
pharmaceutical products
benzodiazepine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308099T
Other languages
English (en)
Inventor
Jiban Kumar Chakrabarti
Terrence Michael Hotten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of ES2062012T3 publication Critical patent/ES2062012T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

TIAZO[1,5]BENZODIAZEPINAS DE FORMULA: (FIG. A), DONDE R1, R2, R3 Y R4 SON INDEPENDIENTEMENTE H, ALQUILO C1-C4, ALQUENILO C2-C4, HALOGENO, HALOALQUILO C1-C4, NITRO, ALCOXI C1-C4, HALOALCOXI C1-C4, ALQUILTIO C1-C4 O FENILSULFONILO; EN LA QUE R5 ES UN GRUPO DE FORMULA: (FIG. B), DONDE R7 ES H, ALQUILO C1-C6, CICLOALQUIL C3-C7 ALQUILO C1-C4, BENCILO O ALQUILO ZO-C2-C6, DONDE Z ES H O UN GRUPO ACILO; R8 ES H O ALQUILO C1-C4; Y N ES 0 O 1; PREVIENDO QUE CUANDO R7 ES H, N ES 0; EN LA QUE R6 ES H, ALQUILO C1-C10,, CICLOALQUILO C3-C7, CICLOALQUIL C3-C7 ALQUILO C1-C4, HALOALQUILO C1-C4, ALCOXI C1-C4 O ALQUILTIO C1-C4; Y EN LA QUE EL GRUPO DE FORMULA: (FIG. C) ES UN ANILLO TIAZOL ELEGIDO DE RADICAL DE FORMULA: (FIG. D) O (FIG. E, Y SUS SALES DE ADICION DE ACIDO. LOS COMPUESTOS TIENE ACTIVIDAD AL SISTEMA NERVIOSO CENTRAL.
ES89308099T 1988-08-11 1989-08-09 Compuestos de benzodiazepina y su uso como productos farmaceuticos. Expired - Lifetime ES2062012T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819059A GB8819059D0 (en) 1988-08-11 1988-08-11 Benzodiazepine compounds & their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2062012T3 true ES2062012T3 (es) 1994-12-16

Family

ID=10641942

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308099T Expired - Lifetime ES2062012T3 (es) 1988-08-11 1989-08-09 Compuestos de benzodiazepina y su uso como productos farmaceuticos.

Country Status (22)

Country Link
US (2) US4977150A (es)
EP (1) EP0354781B1 (es)
JP (1) JP2779219B2 (es)
KR (1) KR0138527B1 (es)
CN (1) CN1025857C (es)
AR (1) AR246972A1 (es)
AT (1) ATE113600T1 (es)
AU (1) AU625067B2 (es)
CA (1) CA1318669C (es)
DE (1) DE68919154T2 (es)
DK (1) DK393489A (es)
ES (1) ES2062012T3 (es)
GB (1) GB8819059D0 (es)
HU (1) HU202239B (es)
IE (1) IE64598B1 (es)
IL (1) IL91246A (es)
MX (1) MX17107A (es)
NZ (1) NZ230251A (es)
PH (1) PH27010A (es)
PT (1) PT91401B (es)
RU (1) RU2002752C1 (es)
ZA (1) ZA896039B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1004596A4 (fr) * 1990-09-26 1992-12-22 Therabel Res S A N V Derives de methylpiperazinoazepine, leur preparation et leur utilisation.
US5627178A (en) 1991-04-23 1997-05-06 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5393752A (en) * 1992-05-26 1995-02-28 Therabel Research S.A./N.V. Methylpiperazinoazepine compounds, preparation and use thereof
US6034078A (en) * 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
ES2297142T3 (es) 2002-03-28 2008-05-01 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina y su uso como antagonistas del receptor de dopamina para el tratamiento de trastornos psicoticos.
ATE361289T1 (de) 2002-08-05 2007-05-15 Lilly Co Eli Piperazinsubstituierte arylbenzodiazepine
WO2005026177A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
DK1838716T3 (da) * 2005-01-05 2011-07-25 Lilly Co Eli Olanzapinpamota-dihydrat

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH468400A (de) * 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
GB1292410A (en) * 1970-05-13 1972-10-11 Yoshitomi Pharmaceutical Thienobenzothiazepine derivatives
CH554362A (de) * 1970-07-30 1974-09-30 Spofa Vereinigte Pharma Werke Verfahren zur herstellung von neuen estern tricyklischer piperazinoalkanole.
US3897446A (en) * 1973-09-04 1975-07-29 Upjohn Co 6-Phenylthiazolo{8 3,2-a{9 {8 1,4{9 benzodiazepin-1-(2H)-ones, and processes
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US3951981A (en) * 1975-02-24 1976-04-20 American Cyanamid Company Substituted benzodiazepines and method of use
US4404137A (en) * 1979-10-16 1983-09-13 Lilly Industries Limited Pyrazolo [3,4-b][1,5]benzodiazepine compounds
US4431589A (en) * 1980-12-11 1984-02-14 Lilly House Benzodiazepine compounds and their use as pharmaceuticals

Also Published As

Publication number Publication date
HUT53109A (en) 1990-09-28
IL91246A0 (en) 1990-03-19
KR0138527B1 (ko) 1998-05-15
CA1318669C (en) 1993-06-01
KR900003179A (ko) 1990-03-23
IL91246A (en) 1994-01-25
AU3939989A (en) 1990-02-15
MX17107A (es) 1993-08-01
AR246972A1 (es) 1994-10-31
DK393489A (da) 1990-02-12
JP2779219B2 (ja) 1998-07-23
JPH02104591A (ja) 1990-04-17
ATE113600T1 (de) 1994-11-15
DE68919154T2 (de) 1995-03-09
EP0354781B1 (en) 1994-11-02
RU2002752C1 (ru) 1993-11-15
US4977150A (en) 1990-12-11
AU625067B2 (en) 1992-07-02
IE892576L (en) 1990-02-11
PT91401A (pt) 1990-03-08
IE64598B1 (en) 1995-08-23
HU202239B (en) 1991-02-28
ZA896039B (en) 1991-04-24
DE68919154D1 (de) 1994-12-08
DK393489D0 (da) 1989-08-10
GB8819059D0 (en) 1988-09-14
CN1040798A (zh) 1990-03-28
EP0354781A2 (en) 1990-02-14
EP0354781A3 (en) 1991-04-03
PH27010A (en) 1993-02-01
US5051516A (en) 1991-09-24
CN1025857C (zh) 1994-09-07
PT91401B (pt) 1995-05-04
NZ230251A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
ES2058105T3 (es) Agentes antiarritmicos.
MX9305566A (es) Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
ES2143526T3 (es) Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos.
ES2169248T3 (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
AR247732A1 (es) Procedimiento para obtener amidas de acido piridin-2, 4- y -2, 5-dicarboxilico
ES2062012T3 (es) Compuestos de benzodiazepina y su uso como productos farmaceuticos.
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
DK0649405T3 (da) 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler.
ES8801803A1 (es) Procedimiento para preparar derivados de cinalina.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
AR027578A1 (es) Derivados de indano
DK0553016T3 (da) Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem
MX9305773A (es) 5-oxo-dibenzo/a,d/ciclohepta-1,4-dienos, procedimiento para su obtencion y medicamentos que los contienen.
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
ES2055717T3 (es) Derivados de benzo- y tieno-3,4-dihidro-piridina, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
ES2117678T3 (es) Derivados de eteres milbemicina, su preparacion y su aplicacion terapeutica y agroquimica.
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354781

Country of ref document: ES